Financhill
Back

Novartis AG 10K Form

Sell
37

NVS
Novartis AG

Last Price:
$105.42
Seasonality Move:
1.66%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NVS News And Ratings

See the #1 stock for the next 7 days that we like better than NVS

NVS Financial Statistics

Sales & Book Value

Annual Sales: $51.7B
Cash Flow: $3.1B
Price / Cash Flow: 15.54
Annual Sales: $22.30
Price / Book: 4.73

Profitability

EPS (TTM): 5.88000
Net Income (TTM): $11.9B
Gross Margin: $38.9B
Return on Equity: 27.64%
Return on Assets: 12%

Novartis AG Earnings Forecast

Key Novartis AG Financial Ratios

  • The Gross Profit Margin over the past 27 years for NVS is 75.20%.
  • The Selling, General & Administrative Expenses for NVS have been equal to 24.30% of Gross Profit Margin.
  • The Research & Development expenses have been 19.38% of Revenue.
  • The Interest Expense is 8.42% of Operating Income.
  • The Net Earning history of NVS is 23.09% of Total Revenues.
  • Per Share Earnings over the last 27 years have been positive in 17 years.

Novartis AG Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: NVS
CUSIP: 66987V
Website: novartis.com

Debt

Debt-to-Equity Ratio: 0.67
Current Ratio: 1.04
Quick Ratio: 0.8

Price-to-Earnings

Trailing P/E Ratio: 17.96
Forward P/E Ratio: 12.11

NVS Technical Analysis vs Fundamental Analysis

Sell
37
Novartis AG (NVS) is a Sell

Is Novartis AG a Buy or a Sell?

  • Novartis AG stock is rated a Sell
    The current Novartis AG [NVS] share price is $105.43. The Score for NVS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.